Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Valeant Pharmaceuticals International (Western & Eastern Europe Operations)

M&A STATUS
301-400 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The company manufactures drugs related to neurology and dermatology in Western and Eastern Europe.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 2150 Street Elzéar Boulevard West
  • Laval, Quebec H7L 4A8
  • Canada

Valeant Pharmaceuticals International (Western & Eastern Europe Operations) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Valeant Pharmaceuticals International (Western & Eastern Europe Operations)‘s full profile, request access.

Request full access to PitchBook

Valeant Pharmaceuticals International (Western & Eastern Europe Operations) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Valeant Pharmaceuticals International (Western & Eastern Europe Operations)‘s full profile, request access.

Request full access to PitchBook

Valeant Pharmaceuticals International (Western & Eastern Europe Operations) Executive Team (1)

Name Title Board
Seat
Contact
Info
Andrew Chang General Manager and Vice-President of US Surgical